MLAB
Mesa Laboratories Inc
132.60$
+2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.6% | +10.2% | -1.2% | -0.6% | +8.7% | -1.1% | -4.2% | +2.0% | +7.2% | -2.2% | -5.6% | – | |
| – | -4.7% | +11.3% | -6.4% | +7.0% | +3.2% | +2.8% | +14.0% | -13.5% | -0.3% | -26.8% | +23.7% | – | |
| – | +4.0% | +9.4% | +1.9% | -4.8% | +12.1% | -3.4% | -15.4% | +14.9% | +12.0% | +11.6% | -16.4% | – | |
| – | -14.0% | +21.1% | -9.0% | -2.1% | +9.0% | +0.9% | -2.2% | +1.3% | -0.4% | +4.3% | -9.9% | – | |
| – | +10.9% | -8.2% | -5.7% | +3.8% | +5.8% | +11.4% | -12.7% | -1.1% | +5.9% | +28.3% | -28.0% | – | |
| – | +4.0% | +819.8% | -89.7% | +0.9% | +6.3% | +8.7% | -20.3% | +10.8% | +3.7% | +29.8% | -27.2% | – | |
| – | – | – | – | -37.1% | +64.7% | -74.6% | +108.6% | +54.2% | +68.8% | -65.5% | +155.9% | – | |
| – | +105.1% | +1.7% | +50.5% | +6.2% | -5.8% | -11.4% | -12.7% | +30.2% | +6.1% | -14.5% | -9.0% | – | |
| – | – | -14,248.6% | – | -2.4% | -158.2% | – | +1,421.0% | -71.5% | +129.9% | -134.7% | – | – | |
| – | – | – | – | -25.7% | -240.9% | – | -70.0% | -121.0% | – | +163.3% | -40.1% | – | |
| – | – | -12,131.3% | – | +1.2% | -148.9% | – | – | -47.8% | +46.6% | -213.9% | – | – | |
| – | +67.4% | -2,178.8% | – | +5.6% | -52.5% | +71.1% | +44.8% | -29.4% | +24.6% | -68.9% | +197.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.